Market Place
Sourcing Support
FDA Rejection Letters Flag Data Concerns For AZ, GSK Biologics
03 Mar 2026 //
FIERCE PHARMA
Pharma Expert Addresses Standardizing CMC Quality Data
06 Feb 2026 //
RAPS
FDA Proposes Febrile Seizure Warnings on Flu Shot Labels
17 Jan 2026 //
FIERCE PHARMA
AZ To Pull Bleeding Reversal Agent After FDA Flags Risk Imbalance
19 Dec 2025 //
FIERCE PHARMA
Merck, Sanofi, AZ Shots For RSV Now Under Scrutiny By FDA
09 Dec 2025 //
FIERCE PHARMA
Astrazeneca Lands OPDP Untitled Letter Over Farxiga TV Ad
17 Nov 2025 //
RAPS
FDA Issues Over 100 Warnings in Ad Crackdown
16 Sep 2025 //
RAPS
AstraZeneca Pharma India surrenders Olaparib marketing authorizat
16 Apr 2025 //
INDPHARMAPOST
BeiGene, ex-AstraZeneca exec faces investigation in China: reports
25 Oct 2024 //
FIERCE PHARMA
DoP Rejects Review Applications on Metoprolol Pricing
24 Oct 2024 //
PHARMABIZ
AZ`s Imfinzi fails in late-stage trial to treat certain lung cancers
26 Jun 2024 //
REUTERS
AstraZeneca`s breast cancer drug combination fails in late-stage trial
19 Jun 2024 //
REUTERS
FDA Rejects AstraZeneca’s Ultomiris Label Expansion in NMOSD
07 Sep 2023 //
BIOSPACE
FDA promotions watchdog delivers first warning letter of the year to AstraZeneca
15 Aug 2023 //
ENDPTS
Emergent Receives FDA Warning Letter Over Quality Control Issues
13 Aug 2022 //
USNEWS
Australia approves Pfizer vaccine, warns of limited global AstraZeneca supply
25 Jan 2021 //
REUTERS
Indian Manufacturer Rejects Claim AstraZeneca-Oxford Covid-19 Vaccine
01 Dec 2020 //
FORBES
Drug wars: how AstraZeneca overtook GSK in UK pharma
27 May 2020 //
FINANCIAL TIMES
AstraZeneca dumps phase 3 renal cell carcinoma program
25 Oct 2019 //
FIERCE BIOTECH
Pfizer recalls migraine med because of bacterial contamination
15 Aug 2019 //
FIERCE PHARMA
Anvisa approved the registration of Lynparza™ Tablets (olaparib)
31 Oct 2018 //
ANVISA
AstraZeneca contracts DPS Group
16 May 2018 //
IN PHARMATECHNOLOGIST
AstraZeneca packing mistakes lead to two recalls, one for BMS
15 Jun 2017 //
FIERCE PHARMA
MoH warns against taking one lot of Brilinta 90 mg for heart attacks and strokes
05 Jun 2017 //
EMIRATES NEWS AGENCY
NPPA`s drug overcharging penalty at a record high
11 Mar 2017 //
BUSINESS STANDARD
Taiwan FDA seeks Crestor recall after counterfeit finds
09 Mar 2017 //
SECURINGINDU
Top pharma cos overcharging, NPPA lists 634 drugs for breaching price cap
27 Feb 2017 //
BUSINESS STANDARD
634 drugs suspected to be not compliant with government price ceiling
24 Feb 2017 //
NEW INDIAN EXPRESS
Five pharmas Fall Foul of ABPI Code of Practice
15 Dec 2016 //
PHARMATIMES
FDA to re-review application for AstraZeneca’s hyperkalaemia treatment
19 Oct 2016 //
EU PHARMACEUTICAL
Judge refuses to block generic versions of AstraZeneca`s Crestor
21 Jul 2016 //
REUTERS
Diabetes rivalries get more complicated with new FDA warning on J&J`s Invokana
15 Sep 2015 //
FIERCE PHARMA
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
29 Aug 2015 //
REUTERS
Boehringer Ingelheim recalls more than 358,000 inhalers
11 Aug 2015 //
FIERCE PHARMA MANUFACTURING
UPDATED: AdverseEvents: Diabetes drug analysis flags heart failure, pancreatitis reports
16 Jun 2015 //
FIERCE PHARMA
FDA to trawl PatientsLikeMe data to identify drug side effects
15 Jun 2015 //
FIRSTWORD PHARMA
AZ escapes censure over cancer tweet
26 May 2015 //
PM LIVE
AstraZeneca AB v. Apotex Corp. (Fed. Cir. 2015)
16 Apr 2015 //
PATENT DOCS
New cancer drugs
01 Apr 2015 //
YAHOO FINANCE
Should FDA Penalize Drug Makers Over Diabetes Drug Ads?
01 Apr 2015 //
PHARMALOT
Faster FDA Spurs Cancer Breakthroughs
24 Mar 2015 //
BLOOMBERG BUSINESS
